scholarly journals Health Resource Utilization (HRU) and Costs for Metastatic Renal Cell Carcinoma (MRCC) Patients Treated With First-Line (1l) Systemic Therapy in The United States

2016 ◽  
Vol 19 (7) ◽  
pp. A755
Author(s):  
S Mhatre ◽  
S Lin ◽  
A Surinach ◽  
R Vohra ◽  
S Satram-Hoang ◽  
...  
Keyword(s):  
United States ◽  
Renal Cell Carcinoma ◽  
Cell Carcinoma ◽  
Resource Utilization ◽  
Systemic Therapy ◽  
Renal Cell ◽  
The United States ◽  
Health Resource ◽  
First Line ◽  
Health Resource Utilization

Prescribing Preferences in the First-Line Treatment for Patients With Metastatic Renal Cell Carcinoma in the United States

2016 ◽  
Vol 14 (5) ◽  
pp. e479-e487 ◽  
Author(s):  
Michelle D. Hackshaw ◽  
Michael Holmes ◽  
Maria Lankford ◽  
Michele Thomas ◽  
Augustina Ogbonnaya ◽  
...  
Keyword(s):  
United States ◽  
Renal Cell Carcinoma ◽  
Cell Carcinoma ◽  
Metastatic Renal Cell Carcinoma ◽  
Renal Cell ◽  
The United States ◽  
Line Treatment ◽  
First Line ◽  
First Line Treatment

Trends of Systemic Therapy Use for Renal Cell Carcinoma in the United States

Urology ◽  
2015 ◽  
Vol 85 (6) ◽  
pp. 1399-1403 ◽  
Author(s):  
Elizabeth K. Ferry ◽  
Brian J. Minnillo ◽  
Matthew J. Maurice ◽  
Robert Abouassaly ◽  
Hui Zhu
Keyword(s):  
United States ◽  
Renal Cell Carcinoma ◽  
Cell Carcinoma ◽  
Systemic Therapy ◽  
Renal Cell ◽  
The United States
Sign in / Sign up

Export Citation Format

Share Document